Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine

Brain Research

Volumn 923, Issue 1-2, 2001, Pages 82-90

  Ardizzone, Timothy D ^a   Bradley, Ronald J ^a,b   Freeman Iii, Arthur M ^b   Dwyer, Donard S ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Antipsychotic drug; Clozapine; Glucose transport; Hyperglycemia; L6 cell; PC12 cell; Risperidone

Indexed keywords

AMOXAPINE; CELL PROTEIN; CLOZAPINE; CLOZAPINE DERIVATIVE; CLOZAPINE N OXIDE; DEOXYGLUCOSE; FLUPHENAZINE; GLUCOSE TRANSPORTER; LOXAPINE; NEUROLEPTIC AGENT; NORCLOZAPINE; RISPERIDONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG INHIBITION; DRUG SENSITIVITY; GLUCOSE TRANSPORT; HYPERGLYCEMIA; IC 50; IN VIVO STUDY; INCUBATION TIME; MUSCLE CELL; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANIMALS; ANTIMETABOLITES; ANTIPSYCHOTIC AGENTS; BIOLOGICAL TRANSPORT; CLOZAPINE; DEOXYGLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HYPERGLYCEMIA; NEURONS; PC12 CELLS; RATS; RISPERIDONE; STRUCTURE-ACTIVITY RELATIONSHIP; TRITIUM;

EID: 0035960878     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)03026-8     Document Type: Article

References (45)

1. Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat
2. Modulation of glucose transport in PC12 Cells by the atypical antipsychotic risperidone and by clozapine and its major metabolites
3. Phenothiazine derivatives and glucose metabolism
4. Some quantitative uses of drug antagonists
5. Psychopharmacology
6. Tissue concentrations of clozapine and its metabolites in the rat
7. Mammalian passive glucose transporters: Members of an ubiquitous family of active and passive transport proteins
8. Proteolytic and chemical dissection of the human erythrocyte glucose transporter
9. Changes in glucose synthesis and utilization in rats treated with chlorpromazine
10. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus
11. Model of the 3-D structure of the GLUT3 glucose transporter and molecular dynamics of glucose transport
12. Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells
13. Attachment of PC12 cells to adhesion substratum induces the accumulation of glucose transporters (GLUTs) and stimulates glucose metabolism
14. Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells
15. Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine
16. Metabolism of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine (clozapine) in mice, dogs and human subjects
17. Influence of patient-related variables on clozapine plasma concentrations
18. Epilepsy and obesity in serotonin 5-HT2C receptor mutant mice
19. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study
20. Hyperglycemia and glycosuria following chlorpromazine therapy
21. Cytochalasin B binding sites and glucose transport carrier in human erythrocyte ghosts
22. Severe hyperglycemia associated with high doses of clozapine
23. Insulin responsiveness in skeletal muscle is determined by glucose transporter (GLUT4) protein levels
24. Clozapine-associated agranulocytosis: Risk and aetiology
25. Clozapine and N-desmethylclozapine are potent 5-HT1c receptor antagonists
26. Clozapine-induced weight gain: Prevalance and clinical relevance
27. Continuous monitoring of extracellular glucose concentrations in the striatum of freely moving rats with an implanted glucose biosensor
28. Expression of two glucose transporters, GLUT1 and GLUT3, in cultured cerebellar neurons: Evidence for neuron specific expression of GLUT3
29. Extracellular glucose concentrations in the rat hippocampus measured by zero-net-flux: Effects of microdialysis flow rate, strain, and age
30. Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2c receptor gene
31. Glycemic effects of chlorpromazine in the mouse, hamster and rat
32. Hyperglycemia and olanzepine
33. The inhibition of glucose transport and cytochalasin B binding activity by tricyclic antidepressants
34. Clozapine and associated diabetes mellitus
35. D2-like dopamine autoreceptor activation reduces quantal size in PC12 cells
36. Some actions of chlorpromazine
37. Dopamine receptor pharmacology
38. The metabolism of atypical antipsychotic drugs: An update
39. Glucose-induced intracellular ion changes in sugar-sensitive hypothalamic neurons
40. Phenothiazines and diabetes in hospitalized women
41. Nonketotic hyperglycemia associated with loxapine and amoxpine: Case report
42. Drug distribution between blood and brain as a determinant of antipsychotic drug effects
43. Bodyweight gain with atypical antipsychotics. A comparative review
44. Novel antipsychotics: Comparison of weight gain liabilities
45. Effects of Desmethylclozapine on Fos protein expression in the forebrain: In Vivo biological activity of the clozapine metabolite